Efficacy and Safety of Eculizumab in the Treatment of Transplant-Associated Thrombotic Microangiopathy: A Systematic Review and Meta-Analysis

BACKGROUND: Transplant-associated thrombotic microangiopathy (TA-TMA) is a dangerous and life-threatening complication in patients undergoing hematopoietic stem cell transplantation (HSCT). Eculizumab has been used in the treatment of TA-TMA, and several studies have confirmed the benefit of Eculizu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Rui, Zhou, Meng, Qi, Jiaqian, Miao, Wenjing, Zhang, Ziyan, Wu, Depei, Han, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856300/
https://www.ncbi.nlm.nih.gov/pubmed/33552043
http://dx.doi.org/10.3389/fimmu.2020.564647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856300/
https://www.ncbi.nlm.nih.gov/pubmed/33552043
http://dx.doi.org/10.3389/fimmu.2020.564647

Ejemplares similares